Antioxidant supplement for superficial brain bleeding symptoms

This study uses a special MRI scan to look for signs of bleeding on the surface of the brain in people with superficial siderosis. It also compares these scans to those of healthy volunteers to improve detection and understanding of the condition.

This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.

This trial tests if combining a minimally invasive surgical procedure with deferoxamine, a drug that helps remove extra iron, improves recovery for people with a type of brain bleed called intracerebral hemorrhage. It aims to see if this combination reduces damage and helps patients regain function better than standard care alone.

This trial tests if IV iron can reduce bleeding symptoms in people with inherited bleeding disorders who also have low iron stores. If you have a condition like von Willebrand disease or a platelet disorder and your iron is low, this treatment might improve your bleeding and quality of life.

This trial compares two types of iron supplements (Sucrosomial Iron and Ferric Maltol) to see which works better and causes fewer side effects in women with low iron levels. It may help if you have mild to moderate anemia and are not taking other iron supplements.

This trial studies whether giving iron through a vein (IV) helps improve anemia caused by heavy uterine bleeding. You may join if you were treated in the emergency department, can go home, and can return for follow-up checks in the next several weeks.